Clinical trials
Phase 1 Hematologic Neoplasms trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2013 | 1 |
| 2016 | 2 |
| 2021 | 1 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| 4SC AG | 1 |
| AbbVie | 1 |
| AstraZeneca | 1 |
| Bayer | 1 |
| Kumquat Biosciences Inc. | 1 |
| Mundipharma Research Limited | 1 |
| Novartis Pharmaceuticals | 1 |
| Prelude Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 8 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Leukemia, Myeloid, Acute | 2 |
| Lymphoma, B-Cell, Marginal Zone | 2 |
| Lymphoma, Mantle-Cell | 2 |
| Multiple Myeloma | 2 |
| Myelodysplastic Syndromes | 2 |
| Recurrence | 2 |
| Hodgkin Disease | 1 |
| Leukemia, Myelomonocytic, Chronic | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.